AC
BOLT icon

Aaron Cowen’s Bolt Biotherapeutics BOLT Stock Holding History

Aaron Cowen’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-133,600
Closed -$3.96M – 91
2022
Q3 		$3.96M Buy
133,600
+22,087
+20% +$914K 0.16% 59
2022
Q2 		$4.55M Hold
111,513
– – 0.17% 66
2022
Q1 		$6.11M Hold
111,513
– – 0.19% 61
2021
Q4 		$10.9M Buy
111,513
+45,238
+68% +$8.59M 0.21% 61
2021
Q3 		$16.8M Buy
66,275
+18,571
+39% +$5.25M 0.28% 53
2021
Q2 		$14.8M Buy
47,704
+26,686
+127% +$10.8M 0.22% 68
2021
Q1 		$13.8M Buy
+21,018
New +$13.7M 0.2% 67

Other funds holding BOLT

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return

Aaron Cowen's BOLT Position: Q4 2022 in Review

Aaron Cowen sold out of Bolt Biotherapeutics (BOLT) in Q4 2022, closing a stake of 133,600 shares — an estimated $3.96M sold.

Aaron Cowen first reported a position in BOLT in Q1 2021 and held it in 7 quarters. The position peaked at $16.8M in Q3 2021. 44 funds tracked by Wall St. Rank hold BOLT as of Q4 2022.

  • Aaron Cowen reported no remaining Bolt Biotherapeutics position as of Q4 2022 after selling out during the quarter.
  • Aaron Cowen sold 133,600 Bolt Biotherapeutics shares in Q4 2022, an estimated $3.96M.
  • Aaron Cowen first reported a position in Bolt Biotherapeutics in Q1 2021 and held it in 7 quarters.
  • Aaron Cowen's Bolt Biotherapeutics position peaked at $16.8M in Q3 2021.
  • 44 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q4 2022.

Based on Suvretta Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.